Asphaug L, Akslen LA, Blix ES, Boge B, Borgen EF, Brekke MB, Falk RS, Geitvik GA, Gilje B, Gravdehaug B, Heie A, Janssen E, Kiserud CE, Kursetgjerde T, Langerød A, Lømo J, Mannsåker B, Mortensen E, Olsson P, Porojnicu AC, Raj SX, Roe OD, Russnes HEG, Skjerven HK, Songe-Møller Set al.(2025) Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives Clin Breast Cancer, 25(6), e721-e730 DOI 10.1016/j.clbc.2025.04.011, PubMed 40348620
Bröckelmann PJ, Böll B, Molin D, Schneider G, Leppä S, Meissner J, Kamper P, Hutchings M, Christensen JH, Schnetzke U, Fuchs M, Jablonski J, Eichenauer DA, von Tresckow B, Klapper W, Kobe C, Borchmann P, Fosså A(2025) Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients Hemasphere, 9(8), e70190 DOI 10.1002/hem3.70190, PubMed 40832013
Dahl AA, Fosså SD(2025) A study of subjective memory impairment in long-term testicular cancer survivors Br J Cancer(in press) DOI 10.1038/s41416-025-03108-z, PubMed 40640494
